semaglutide clinical trials AHA 2024: continues to impress in diabetic kidney disease Results from the latest clinical

[25] Hodson M, Feustel P, Davis L

Tirzepatide combines GLP-1 and GIP receptor activity and has demonstrated effects on glucose regulation and body weight in approved clinical use

Diet does much of this work (see below), and some people also consider a targeted supplement

A 2009 study published in the Journal of Inflammation (London) has found that Lactobacillus Casei probiotics may help to regulate coagulation and reduce blood clotting ( 41 )

By activating the same receptors, GLP-1 drugs enhance those fullness signals, so you feel satisfied sooner and with less food

Start with your most pressing issue rather than focusing on a lengthy feature list